243 related articles for article (PubMed ID: 15019073)
41. Preparation and evaluation of chitosan microspheres containing bisphosphonates.
Patashnik S; Rabinovich L; Golomb G
J Drug Target; 1997; 4(6):371-80. PubMed ID: 9239577
[TBL] [Abstract][Full Text] [Related]
42. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
43. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
44. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
Gu YH; Wang LY; Tan TW; Ma GH
Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
[TBL] [Abstract][Full Text] [Related]
45. Preparation and preliminary characterization of concentric multi-walled chitosan microspheres.
Chang SJ; Niu GC; Kuo SM; Chen SF
J Biomed Mater Res A; 2007 Jun; 81(3):554-66. PubMed ID: 17133452
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
Davis JL; Salmon JH; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
[TBL] [Abstract][Full Text] [Related]
47. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
48. A novel microsphere with a three-layer structure for duodenum-specific drug delivery.
Zhu X; Zhou D; Jin Y; Song YP; Zhang ZR; Huang Y
Int J Pharm; 2011 Jul; 413(1-2):110-8. PubMed ID: 21536116
[TBL] [Abstract][Full Text] [Related]
49. Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Lin YH; Chang CH; Wu YS; Hsu YM; Chiou SF; Chen YJ
Biomaterials; 2009 Jul; 30(19):3332-42. PubMed ID: 19299008
[TBL] [Abstract][Full Text] [Related]
50. Chitosan microspheres as a potential carrier for drugs.
Sinha VR; Singla AK; Wadhawan S; Kaushik R; Kumria R; Bansal K; Dhawan S
Int J Pharm; 2004 Apr; 274(1-2):1-33. PubMed ID: 15072779
[TBL] [Abstract][Full Text] [Related]
51. Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy.
Gaspar MC; Sousa JJ; Pais AA; Cardoso O; Murtinho D; Serra ME; Tewes F; Olivier JC
Eur J Pharm Biopharm; 2015 Oct; 96():65-75. PubMed ID: 26192459
[TBL] [Abstract][Full Text] [Related]
52. Enhancing drug incorporation into tetracycline-loaded chitosan microspheres for periodontal therapy.
Govender S; Lutchman D; Pillay V; Chetty DJ; Govender T
J Microencapsul; 2006 Nov; 23(7):750-61. PubMed ID: 17123919
[TBL] [Abstract][Full Text] [Related]
53. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
54. Adsorption of bilirubin by amine-containing crosslinked chitosan resins.
Yu Y; He B; Gu H
Artif Cells Blood Substit Immobil Biotechnol; 2000 Jul; 28(4):307-20. PubMed ID: 10928701
[TBL] [Abstract][Full Text] [Related]
55. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
Wang LY; Ma GH; Su ZG
J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
[TBL] [Abstract][Full Text] [Related]
56. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system.
Jameela SR; Kumary TV; Lal AV; Jayakrishnan A
J Control Release; 1998 Mar; 52(1-2):17-24. PubMed ID: 9685932
[TBL] [Abstract][Full Text] [Related]
57. Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release.
Huang RG; Schwartz JB; Ofner CM
Pharm Dev Technol; 1999 Jan; 4(1):107-15. PubMed ID: 10027219
[TBL] [Abstract][Full Text] [Related]
58. A novel method for the synthesis of the PEG-crosslinked chitosan with a pH-independent swelling behavior.
Kulkarni AR; Hukkeri VI; Sung HW; Liang HF
Macromol Biosci; 2005 Oct; 5(10):925-8. PubMed ID: 16208628
[TBL] [Abstract][Full Text] [Related]
59. Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study.
Shen EC; Wang C; Fu E; Chiang CY; Chen TT; Nieh S
J Periodontal Res; 2008 Dec; 43(6):642-8. PubMed ID: 18624950
[TBL] [Abstract][Full Text] [Related]
60. Suppressive effect of rice extract on Helicobacter pylori infection in a Mongolian gerbil model.
Murakami M; Ota H; Sugiyama A; Ishizone S; Maruta F; Akita N; Okimura Y; Kumagai T; Jo M; Tokuyama T
J Gastroenterol; 2005 May; 40(5):459-66. PubMed ID: 15942710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
